Asthma inhaler switch in 2024 could leave some patients scrambling
A popular asthma inhaler is being discontinued Jan. 1, fueling concerns that patients may have trouble getting insurance coverage for alternatives.
Dec 29, 2023
0
0
A popular asthma inhaler is being discontinued Jan. 1, fueling concerns that patients may have trouble getting insurance coverage for alternatives.
Dec 29, 2023
0
0
What role do omega-6 fatty acids play in cardiovascular disease and diabetes? Scientists from Mannheim, together with researchers from Heidelberg, Frankfurt, and Hangzhou in China, have investigated the breakdown of omega-6 ...
Dec 21, 2023
0
37
In cases of opioid use disorder, short-term medically managed withdrawal (commonly known as detox) and long-term rehabilitation treatments that don't incorporate continued use of buprenorphine or methadone are no more effective ...
Dec 19, 2023
0
4
Psychiatric and neurological disorders are widespread, yet the pace of drug development for these conditions lags far behind that of heart disease, cancer, and other conditions. Brain disorders are difficult to study and ...
Dec 19, 2023
0
34
B cell deficiency is a common condition that can result either from immunosuppressant drugs used to treat autoimmune disease or certain cancers—such as rituximab (RTX)—or from natural immune deficiency. These patients ...
Dec 18, 2023
0
44
Prescription drugs and vaccines revolutionized health care, dramatically decreasing death from disease and improving quality of life across the globe. But how do researchers, universities and hospitals, and the pharmaceutical ...
Dec 14, 2023
0
0
People living in less populated, rural or remote areas are missing out on last-ditch but potentially life-saving cancer clinical trials, according to a recent study by a University of Alberta oncologist that puts the onus ...
Dec 12, 2023
0
0
The combination of polihexanide (PHMB) and propamidine is safe and effective for treating the rare sight-threatening eye infection Acanthamoeba keratitis (AK), according to a study recently published in Ophthalmology.
Dec 9, 2023
0
0
Tardive dyskinesia (TD) poses a substantial burden for both caregivers and patients, according to a study published online Nov. 28 in the Journal of Patient-Reported Outcomes.
Dec 8, 2023
0
16
The Biden administration is flexing some federal muscle in its push for lower drug prices, warning pharmaceutical companies that it might use its authority to cancel patent protections if a medication costs too much.
Dec 7, 2023
0
10